Globular adiponectin augments insulin secretion from pancreatic Islet β cells at high glucose concentrations

Weiqiong Gu,Xiaoying Li,Changqin Liu,Jun Yang,Lei Ye,Jingfen Tang,Yuanjun Gu,Yisheng Yang,Jie Hong,Yifei Zhang,Mingdao Chen,Guang Ning
DOI: https://doi.org/10.1385/ENDO:30:2:217
2006-01-01
Endocrine
Abstract:Adiponectin plays an important role in improving insulin resistance and preventing atherosclerosis. However it has been rarely reported that adiponectin influences insulin secretion because its receptor was identified in human islet β cells. In order to investigate the direct effect of adiponectin on pancreatic islet β cells, we performed an insulin secretion test in purified rat islets, which were incubated with adiponectin (100 ng/mL) at low (3.3 m M ) and high (16.7 m M ) glucose concentrations. Furthermore, cell lysates were extracted from the adiponectin-treated islets for p-AMPKα assay. RTPCR and immunohistochemical examination showed both adiponectin receptor 1 (AdipoR1) and receptor 2 (A dipoR2) were expressed in islet cells and AdipoR1 was predominantly expressed. Insulin secretion was significantly increased in the presence of adiponectin for 6 h at high glucose concentration. Meanwhile, the levels of phosphorylated AMPK increased with adiponectin treatment at high glucose concentrations. It is concluded that adiponectin augments insulin secretion from pancreatic islet β cells at high glucose concentration through AMPK activation.
What problem does this paper attempt to address?